Evidence map›Paper›PMID 38902426›Full record

SynthesisJournal of ultrasound2025

Percutaneous radiofrequency ablation of ovarian cancer metastasis in the spleen: a therapeutic option to consider.

Andrea Boccatonda, Paula Antonia Mauloni, Monica Cevenini, Livia Masi, Sofia Maria Bakken, Carla Serra

Abstract readCase ReportsSystematic Review
In one paragraph

Synthesis in Journal of ultrasound, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrea BoccatondaDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.ORCID http://orcid.org/0000-0001-9303-7790
Paula Antonia MauloniInterventional Diagnostic and Therapeutical Ultrasound Unit, Department of Organ Failure and Transplantation S, Orsola-Malpighi Hospital-University of Bologna, Via Massarenti N 9, 40138, Bologna, BO, Italy.
Monica CeveniniInterventional Diagnostic and Therapeutical Ultrasound Unit, Department of Organ Failure and Transplantation S, Orsola-Malpighi Hospital-University of Bologna, Via Massarenti N 9, 40138, Bologna, BO, Italy.
Livia MasiInterventional Diagnostic and Therapeutical Ultrasound Unit, Department of Organ Failure and Transplantation S, Orsola-Malpighi Hospital-University of Bologna, Via Massarenti N 9, 40138, Bologna, BO, Italy.
Sofia Maria BakkenInterventional Diagnostic and Therapeutical Ultrasound Unit, Department of Organ Failure and Transplantation S, Orsola-Malpighi Hospital-University of Bologna, Via Massarenti N 9, 40138, Bologna, BO, Italy.
Carla SerraInterventional Diagnostic and Therapeutical Ultrasound Unit, Department of Organ Failure and Transplantation S, Orsola-Malpighi Hospital-University of Bologna, Via Massarenti N 9, 40138, Bologna, BO, Italy. carla.serra@aosp.bo.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Splenic metastasis are rare clinical entities developing in less than 1% of all metastatic cancers and usually in the setting of disseminated disease. To date, splenectomy is traditionally the first line therapy in patient with splenic metastasis, however non-surgical therapies have been reported. Here we described the case of a 57-year-old patient with splenic metastasis from ovarian cancer successfully treated by percutaneous radiofrequency ablation. Furthermore, we performed a literature systematic review of the cases of splenic metastases treated by thermal ablation.

Indexed as

Ovarian NeoplasmsRadiofrequency AblationSplenic NeoplasmsFemaleHumansMiddle AgedSpleenTomography, X-Ray ComputedMetastasisOvarian cancerRadiofrequency ablationSpleenThermal ablation

Identifiers

PMID38902426
PMCPMC11947324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.